AVDL logo

Avadel Pharmaceuticals plc (AVDL) Depreciation and amortization

annual D&A:

$2.68M+$915.00K(+51.81%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual depreciation & amortization is $2.68 million, with the most recent change of +$915.00 thousand (+51.81%) on December 31, 2024.
  • During the last 3 years, AVDL annual D&A has risen by +$1.87 million (+228.96%).
  • AVDL annual D&A is now -81.50% below its all-time high of $14.49 million, reached on December 31, 2016.

Performance

AVDL Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

quarterly D&A:

$1.14M+$316.00K(+38.30%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly depreciation & amortization is $1.14 million, with the most recent change of +$316.00 thousand (+38.30%) on June 1, 2025.
  • Over the past year, AVDL quarterly D&A has increased by +$707.90 thousand (+163.45%).
  • AVDL quarterly D&A is now -71.60% below its all-time high of $4.02 million, reached on June 30, 2016.

Performance

AVDL quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

TTM D&A:

$3.64M+$707.90K(+24.18%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL TTM depreciation & amortization is $3.64 million, with the most recent change of +$707.90 thousand (+24.18%) on June 1, 2025.
  • Over the past year, AVDL TTM D&A has increased by +$2.10 million (+137.12%).
  • AVDL TTM D&A is now -74.24% below its all-time high of $14.11 million, reached on December 31, 2016.

Performance

AVDL TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

AVDL Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+51.8%+163.4%+137.1%
3 y3 years+229.0%+387.6%+320.9%
5 y5 years+7.8%+119.9%+53.1%

AVDL Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+229.0%at high+3003.3%at high+320.9%
5 y5-yearat high+229.0%at high+3003.3%at high+361.3%
alltimeall time-81.5%+283.0%-71.6%+3003.3%-74.2%+1717.8%

AVDL Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.14M(+38.3%)
$3.64M(+24.2%)
Mar 2025
-
$825.00K(+35.3%)
$2.93M(+10.7%)
Dec 2024
$2.68M(+51.8%)
$609.80K(-42.5%)
$2.64M(+32.5%)
Sep 2024
-
$1.06M(+144.7%)
$1.99M(+30.1%)
Jun 2024
-
$433.10K(-19.9%)
$1.53M(-10.3%)
Mar 2024
-
$541.00K(-1476.6%)
$1.71M(-2.7%)
Dec 2023
$1.77M(+18.3%)
-$39.30K(-106.6%)
$1.76M(-26.5%)
Sep 2023
-
$598.50K(-1.8%)
$2.39M(+11.0%)
Jun 2023
-
$609.50K(+3.7%)
$2.15M(+21.1%)
Mar 2023
-
$588.00K(-1.1%)
$1.78M(+22.7%)
Dec 2022
$1.49M(+83.2%)
$594.50K(+64.4%)
$1.45M(+39.5%)
Sep 2022
-
$361.60K(+54.5%)
$1.04M(+20.2%)
Jun 2022
-
$234.00K(-9.7%)
$863.90K(+4.2%)
Mar 2022
-
$259.00K(+40.8%)
$829.10K(+5.2%)
Dec 2021
$815.00K(-51.8%)
$184.00K(-1.6%)
$788.10K(-22.8%)
Sep 2021
-
$186.90K(-6.2%)
$1.02M(-15.6%)
Jun 2021
-
$199.20K(-8.6%)
$1.21M(-20.9%)
Mar 2021
-
$218.00K(-47.7%)
$1.53M(-13.5%)
Dec 2020
$1.69M(-32.0%)
$416.60K(+10.8%)
$1.77M(-17.4%)
Sep 2020
-
$375.90K(-27.5%)
$2.14M(-9.9%)
Jun 2020
-
$518.80K(+13.8%)
$2.38M(-6.7%)
Mar 2020
-
$456.00K(-42.2%)
$2.55M(+3.5%)
Dec 2019
$2.49M(-66.5%)
$788.50K(+28.8%)
$2.46M(-27.0%)
Sep 2019
-
$612.10K(-11.2%)
$3.37M(-25.0%)
Jun 2019
-
$689.50K(+86.9%)
$4.49M(-19.3%)
Mar 2019
-
$369.00K(-78.3%)
$5.57M(-22.5%)
Dec 2018
$7.43M(+52.2%)
$1.70M(-2.1%)
$7.19M(-7.3%)
Sep 2018
-
$1.74M(-1.8%)
$7.76M(+7.6%)
Jun 2018
-
$1.77M(-11.0%)
$7.21M(+15.5%)
Mar 2018
-
$1.99M(-12.5%)
$6.24M(+22.5%)
Dec 2017
$4.88M(-66.3%)
$2.27M(+90.6%)
$5.10M(-4.9%)
Sep 2017
-
$1.19M(+48.6%)
$5.36M(-32.9%)
Jun 2017
-
$800.90K(-4.3%)
$7.98M(-28.7%)
Mar 2017
-
$837.00K(-66.9%)
$11.20M(-20.7%)
Dec 2016
$14.49M(+10.3%)
$2.53M(-33.7%)
$14.11M(+21.8%)
Sep 2016
-
$3.81M(-5.1%)
$11.59M(+49.1%)
Jun 2016
-
$4.02M(+7.0%)
$7.77M(+107.0%)
Mar 2016
-
$3.75M(+15.2%)
$3.75M(-71.1%)
Dec 2015
$13.13M(-7.1%)
-
-
Mar 2015
-
$3.26M(+21.7%)
$13.01M(-2.3%)
Dec 2014
$14.14M
$2.68M(-21.8%)
$13.32M(+16.6%)
Sep 2014
-
$3.42M(-6.1%)
$11.42M(+30.1%)
Jun 2014
-
$3.65M(+2.1%)
$8.78M(+49.1%)
DateAnnualQuarterlyTTM
Mar 2014
-
$3.57M(+356.3%)
$5.89M(+87.5%)
Dec 2013
$3.06M(-3.8%)
$782.40K(+0.1%)
$3.14M(+33.2%)
Sep 2013
-
$781.80K(+3.8%)
$2.36M(+49.6%)
Jun 2013
-
$753.40K(-8.3%)
$1.58M(-3.4%)
Mar 2013
-
$822.00K(+1.6%)
$1.63M(-41.1%)
Dec 2012
$3.18M(-4.9%)
-
-
Jun 2012
-
$809.00K(+14.3%)
$2.77M(-5.2%)
Mar 2012
-
$708.00K(+27.5%)
$2.92M(-9.9%)
Dec 2011
$3.35M(-28.7%)
$555.40K(-20.2%)
$3.24M(-20.3%)
Sep 2011
-
$695.80K(-27.7%)
$4.06M(+20.7%)
Jun 2011
-
$962.10K(-6.4%)
$3.37M(+40.0%)
Mar 2011
-
$1.03M(-25.4%)
$2.41M(+74.6%)
Dec 2010
$4.70M(-20.6%)
$1.38M(-28.0%)
$1.38M(-79.0%)
Dec 2009
$5.92M(-18.4%)
-
-
Dec 2008
$7.25M(+17.0%)
-
-
Dec 2007
$6.20M(+9.9%)
$1.91M(+19.7%)
$6.56M(-0.1%)
Sep 2007
-
$1.60M(+2.2%)
$6.56M(+5.0%)
Jun 2007
-
$1.56M(+5.9%)
$6.25M(+7.1%)
Mar 2007
-
$1.48M(-23.0%)
$5.84M(+3.5%)
Dec 2006
$5.64M(+18.9%)
$1.92M(+49.1%)
$5.64M(+14.5%)
Sep 2006
-
$1.29M(+11.8%)
$4.92M(+0.6%)
Jun 2006
-
$1.15M(-9.9%)
$4.90M(-4.9%)
Mar 2006
-
$1.28M(+6.1%)
$5.15M(+8.6%)
Dec 2005
$4.74M(+87.5%)
$1.21M(-4.3%)
$4.74M(+7.8%)
Sep 2005
-
$1.26M(-10.3%)
$4.40M(+14.6%)
Jun 2005
-
$1.41M(+61.1%)
$3.84M(+37.1%)
Mar 2005
-
$872.00K(+1.0%)
$2.80M(+10.7%)
Dec 2004
$2.53M(+47.8%)
$863.00K(+23.3%)
$2.53M(-8.8%)
Sep 2004
-
$700.00K(+91.8%)
$2.77M(+33.7%)
Jun 2004
-
$365.00K(-39.4%)
$2.08M(+11.9%)
Mar 2004
-
$602.00K(-45.7%)
$1.85M(+8.4%)
Dec 2003
$1.71M(+17.3%)
$1.11M(>+9900.0%)
$1.71M(+183.4%)
Sep 2003
-
$0.00(-100.0%)
$604.00K(0.0%)
Jun 2003
-
$145.00K(-68.4%)
$604.00K(+31.6%)
Mar 2003
-
$459.00K(+129.5%)
$459.00K(+129.5%)
Dec 2002
$1.46M(+15.0%)
-
-
Dec 2001
$1.27M(+14.1%)
-
-
Dec 2000
$1.11M(-7.8%)
-
-
Dec 1999
$1.21M(+15.9%)
-
-
Dec 1998
$1.04M(+48.7%)
-
-
Mar 1998
-
$200.00K(0.0%)
$200.00K(0.0%)
Dec 1997
$700.00K(-22.2%)
-
-
Dec 1996
$900.00K
-
-
Mar 1996
-
$200.00K
$200.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual depreciation & amortization?
  • What is the all time high annual D&A for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual D&A year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly D&A year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM depreciation & amortization?
  • What is the all time high TTM D&A for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM D&A year-on-year change?

What is Avadel Pharmaceuticals plc annual depreciation & amortization?

The current annual D&A of AVDL is $2.68M

What is the all time high annual D&A for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual depreciation & amortization is $14.49M

What is Avadel Pharmaceuticals plc annual D&A year-on-year change?

Over the past year, AVDL annual depreciation & amortization has changed by +$915.00K (+51.81%)

What is Avadel Pharmaceuticals plc quarterly depreciation & amortization?

The current quarterly D&A of AVDL is $1.14M

What is the all time high quarterly D&A for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly depreciation & amortization is $4.02M

What is Avadel Pharmaceuticals plc quarterly D&A year-on-year change?

Over the past year, AVDL quarterly depreciation & amortization has changed by +$707.90K (+163.45%)

What is Avadel Pharmaceuticals plc TTM depreciation & amortization?

The current TTM D&A of AVDL is $3.64M

What is the all time high TTM D&A for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM depreciation & amortization is $14.11M

What is Avadel Pharmaceuticals plc TTM D&A year-on-year change?

Over the past year, AVDL TTM depreciation & amortization has changed by +$2.10M (+137.12%)
On this page